-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2019 to Q4 2022.
- CASI Pharmaceuticals, Inc (DE) Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2022 was 13.6M shares, a 0.27% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13.6M shares, a 0.27% increase from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 13.6M shares, a 23.2% increase from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 11M shares, a 11412% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)